ELPEN Pharmaceutical Co. Inc.

ELPEN is a privately family-owned, middle sized Greek pharmaceutical company with operations worldwide. Established in 1965, the group currently has more than 1200 employees and an annual turnover of €250 million. With state of the art production (facility of 10.000m2) and research facilities, ELPEN specializes in the development, production and commercialization of branded generic products to more than 40 countries worldwide. ELPEN is  investing  in a  Biomedical Research & Innovation Park, “Athens LifeTech Park”, that will host a  Biotech Incubator, a ...